Creatine and phosphocreatine analogs: Anticancer activity and enzymatic analysis

Oncology Research

Volumn 8, Issue 3, 1996, Pages 121-130

  Bergnes, Gustave ^a   Yuan, Wei ^a   Khandekar, Vrinda S ^a   O'Keefe, Margaret M ^a   Martin, Katherine J ^a   Teicher, Beverly A ^b   Kaddurah Daouk, Rima ^a,c  

^a Amira Corporation   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c Bldg 200   (United States)

Author keywords

analogs; antitumor; creatine; creatine kinase; kinetics; phosphocreatine

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CREATINE KINASE; CYCLOCREATINE; CYCLOPHOSPHAMIDE; DOXORUBICIN;

ANIMAL CELL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER INHIBITION; CELL TRANSFORMATION; COLON CANCER; CYTOTOXICITY; ENZYME SYNTHESIS; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; UTERINE CERVIX CANCER;

EID: 0029893875     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. 1. Wallimann, T.; Wyss, M.; Brdiczka, D.; Nicolay, K.; Eppenberger, H. M. Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the "phosphocreatine circuit" for cellular energy homeostasis. Biochem. J. 281:21-40; 1992.
2. 2. Bessman, S. P.; Carpenter, C. L. The creatine-creatine phosphate energy shuttle. Annu. Rev. Biochem. 54: 831-862; 1985.
3. 3. Kaddurah-Daouk, R.; Lillie, J. W.; Daouk, G. H.; Green, M. R.; Kingston, R.; Schimmel, P. Induction of a cellular enzyme for energy metabolism by transforming domains of adenovirus Ela. Mol. Cell. Biol. 10:1476-1483; 1990.
4. 4. Zhao, J.; Schmieg, I.; Simmons, T.; Molloy, G. R. Mouse p53 represses the rat brain creatine kinase gene but activates the rat muscle creatine kinase gene. Mol. Cell. Biol. 14:8483-8492; 1994.
5. 5. Rowley, G. L.; Greenleaf, A. L.; Kenyon, G. L. On the specificity of creatine kinase. New glycocyamines and glycocyamine analogs related to creatine. J. Am. Chem. Soc. 93:5542-5551; 1971.
6. 6. Dietrich, R. E; Miller, R. B.; Kenyon, G. L.; Leyh, T. S.; Reed, G. H. Conformationally restricted creatine analogues and substrate specificity of rabbit muscle creatine kinase. Biochemistry 19:3180-3186; 1980.
7. 7. Walker, J. B. Bioenergetic engineering with guanidino compounds. Loading tissues with extended-range synthetic thermodynamic buffers. In: De Deyn, P. P.; Marescau, B.; Stalon, V.; Qureshi, I. A., eds. Guanidino compounds in biology and medicine. London: John Libbey and Company; 1992:pp. 187-194.
8. 8. Lillie, J. W.; O'Keefe, M.; Valinski, H.; Hamlin, A.; Varban, M. L.; Kaddurah-Daouk, R. Cyclocreatine (1-carboxymethyl-2-iminoimidazolidine) inhibits the growth of a broad spectrum of cancer cells derived from solid tumors. Cancer Res. 53:1-7; 1993.
9. 9. Martin, K. J.; Chen, S.-F.; Clark, G. M.; Degen, D.; Wajima, M.; Von Hoff, D. D.; Kaddurah-Daouk, R. Evaluation of creatine analogs as a new class of anticancer agents using freshly explanted human tumor cells. J. Natl. Cancer Inst. 86:608-613; 1994.
10. 10. Teicher, B. A.; Menon, K.; Northey, D.; Liu, J.; Kufe, D. W.; Kaddurah-Daouk, R. Cyclocreatine in cancer chemotherapy. Cancer Chemother. Pharmacol. 35: 411-416; 1994.
11. 11. Hoosein, N. M.; Martin, K. J.; Abdul, M.; Logothetis, C. J.; Kaddurah-Daouk, R. Antiproliferative effects of cyclocreatine on human prostatic carcinoma cells. Anticancer Res. 15:1339-1342; 1995.
12. 12. Miller, E. E.; Evans, A. E.; Cohn, M. Inhibition of tumor growth by creatine and cyclocreatine. Proc. Natl. Acad. Sci. USA 90:3304-3308; 1993.
13. 13. Martin, K. J.; Winslow, E. R.; Kaddurah-Daouk, R. Cell cycle studies of cyclocreatine, a new anticancer agent. Cancer Res. 54:5160-5165; 1994.
14. 14. Martin, K. J.; Vassallo, C. V.; Teicher, B. A.; Kaddurah-Daouk, R. Microtubule stabilization and potentiation of Taxol activity by a creatine analog cyclocreatine. Anticancer Drugs 6:419-426; 1995.
15. 15. Wang, T. Synthesis and properties of N-acetimidoyl derivatives of glycine and sarcosine. J. Org. Chem. 39: 3591-3594; 1974.
16. 16. Roberts, J. J.; Walker, J. B. Synthesis and accumulation of an extremely stable high-energy phosphate compound by muscle, heart, and brain of animals fed the creatine analog, 1-carboxyethyl-2-iminoimidazolidine (homocyclocreatine). Arch. Biochem. Biophys. 220:563-571; 1983.
17. 17. Roberts, J. J.; Walker, J. B. Higher homolog and N-ethyl analog of creatine as synthetic phosphagen precursors in brain, heart, and muscle, repressors of liver amidino-transferase, and substrates for creatine catabolic enzymes. J. Biol. Chem. 260:13502-13508; 1985.
18. 18. Annesley, T. M.; Walker, J. B. Cyclocreatine phosphate as a substitute for creatine phosphate in vertebrate tissues. Energetic considerations. Biochem. Biophys. Res. Commun. 74:185-190; 1977.
19. 19. Cramer, F.; Scheiffele, E.; Vollmar, A. Die synthese der argininphosphorsäure und die reaktion von isoureidophosphonaten mit aminen. Chem. Ber. 95:1670-1682; 1962.
20. 20. Uhing, E.; Rattenbury, K.; Toy, A. D. F. Chemistry of chloromethylphosphinic acid. I. Preparation and alkaline hydrolysis. J. Am. Chem. Soc. 83:2299-2303; 1961.
21. 21. Bernt, E.; Bergmeyer, H. U.; Mollering, H. Creatine. In: Bergmeyer, H. U., Gawehn, K., eds. Methods of enzymatic analysis. Vol. 4. New York: Academic Press; 1974: pp. 1772-1776.
22. 22. Lamrecht, W.; Stain, P.; Heinz, F.; Waisser, H. Creatine phosphate. Determination with creatine kinase, hexokinase, and glucose-6-phosphate dehydrogenase. In: Bergmeyer, H. U., Gawehn, K. eds. Methods of enzymatic analysis. Vol. 4. New York: Academic Press; 1974: pp. 1777-1781.
23. 23. Segaloff, A. Hormones and breast cancer. Recent Prog. Horm. Res. 22:351-374; 1966.
24. 24. Muhlebach, S. M.; Gross, M.; Wirz, T.; Wallimann, T.; Perriard, J. C.; Wyss, M. Sequence homology and structure predictions of the creatine kinase isoenzymes. Mol. Cell. Biochem. 133-134:245-262; 1994.
25. 25. McLaughlin, A. C.; Cohn, M.; Kenyon, G. L. Specificity of creatine kinase for guanidino substrates. Kinetic and proton nuclear magnetic relaxation rate studies. J. Biol. Chem. 247:4382-4388; 1975.
26. 26. Griffiths, G. R.; Walker, J. B. Accumulation of analog of phosphocreatine in muscle of chicks fed 1-carboxymethyl-2-iminoimidazolidine (cyclocreatine). J. Biol. Chem. 251:2049-2054; 1976.
27. 27. Annesley, T. M.; Walker, J. B. Energy metabolism of skeletal muscle containing cyclocreatine phosphate. J. Biol. Chem. 255:3924-3930; 1980.
28. 28. Ohira, Y.; Ishine, S.; Inoue, N.; Yunoki, K. Reduced growth of Ehrlich ascites tumor cells in creatine-depleted mice fed β-guanidinopropionic acid. Biochem. Biophys. Acta 1097:117-122; 1991.
29. 29. Dreskin, S. C.; Kuhn, D. E.; Huang, Y. Phosphoenol pyruvate and creatine phosphate augment ATP and magnesium-dependent Fc epsilon RI-mediated activation of phospholipase c in RBL cell ghosts. J. Immunol. 151: 3199-3205; 1993.
30. 30. Schimmel, L.; Khandekar, V. S.; Martin, K. J.; Riera, T.; Honan, C.; Shaw, D. G.; Kaddurah-Daouk, R. The synthetic phosphagen cyclocreatine phosphate inhibits the growth of a broad spectrum of solid tumors. Anticancer Res.:16:375-380; 1996.
31. 31. Saks, V. A.; Dzhaliashvili, I. V.; Konorev, E. A.; Strumia, E. Molecular and cellular aspects of the cardio-protective effect of phosphocreatine. Biokhimiya 57: 1763-1784; 1992.
32. 32. Saks,V. A.; Kapelko, V. I.; Ruda, M. Y.; Semenovsky, M. L., Strumia, E. Phosphocreatine as effective drug in clinical cardiology. In: De Deyn, P. P.; Marescau, B.; Stalon, V.; Qureshi, I. A., eds. Guanidino compounds in biology and medicine. London: John Libbey and Company Ltd.; 1992:pp. 239-248.